ethinyl estradiol has been researched along with c-peptide in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaspard, UJ; Humblet, DM; Jaminet, CB; Jandrain, BJ; Lefebvre, PJ; Scheen, AJ | 2 |
| Balint-Perić, L; Prelević, GM; Trpković, D; Würzburger, MI | 1 |
| Godsland, IF; Jacobs, HS; Seed, M; Wynn, V | 1 |
| van den Ende, A; van Wayjen, RG | 1 |
| Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
| Crook, D; Felton, C; Godsland, IF; Proudler, AJ; Sidhu, M; Stevenson, JC; Worthington, M | 1 |
| Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO | 1 |
| Demeyer, F; Gaspard, UJ; Lefebvre, P; Lüdicke, F; Scheen, A | 1 |
| Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 1 |
| Buicu, C; Endrikat, J; Gaspard, U; Gerlinger, C; Heithecker, R; Lefebvre, P; Scheen, A | 1 |
| Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
| Düsterberg, B; Endrikat, J; Gerlinger, C; Goldstein, H; Jespersen, J; Schmidt, W; Skouby, SO; Wessel, J | 1 |
| Cagnacci, A; Ferrari, S; Tirelli, A; Volpe, A; Zanin, R | 1 |
| Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Palombo-Kinne, E; Sänger, N; Stahlberg, S; Wiegratz, I | 1 |
| Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
9 trial(s) available for ethinyl estradiol and c-peptide
| Article | Year |
|---|---|
Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
Topics: Adult; Blood Glucose; C-Peptide; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Prospective Studies; Random Allocation; Reference Values | 1990 |
Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
Topics: Acne Vulgaris; Adrenocorticotropic Hormone; Blood Glucose; C-Peptide; Cyproterone Acetate; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hirsutism; Humans; Hysterectomy; Insulin; Kinetics; Postmenopause; Prolactin; Prospective Studies; Retrospective Studies | 1995 |
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides | 1999 |
Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism.
Topics: Adult; Blood Glucose; C-Peptide; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Uterine Hemorrhage | 2002 |
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.
Topics: Adolescent; Adult; Androstenes; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics | 2003 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Denmark; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids, Nonesterified; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Prospective Studies; Time Factors; Treatment Outcome; Triglycerides | 2005 |
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Liver Function Tests; Luteinizing Hormone; Young Adult | 2009 |
Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Menstruation; Nandrolone; Prospective Studies; Young Adult | 2010 |
7 other study(ies) available for ethinyl estradiol and c-peptide
| Article | Year |
|---|---|
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Apolipoproteins; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Lipid Metabolism; Male; Polycystic Ovary Syndrome; Triglycerides | 1990 |
The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Hirsutism; Humans; Insulin; Insulin Resistance; Tolbutamide | 1984 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Blood Glucose; C-Peptide; Cholesterol, HDL; Cholesterol, VLDL; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Triglycerides | 1993 |
Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism.
Topics: Adult; C-Peptide; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Metabolic Clearance Rate | 1993 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |